MedPath

Effect of Olanzapine and Aripiprazole in schizophrenic patients

Phase 2
Conditions
Schizophrenia.
Schizophrenia
Registration Number
IRCT2013090714577N1
Lead Sponsor
Research deputy of Ardabil University of Medical Science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
80
Inclusion Criteria

Diagnosis of schizophrenia according to the criteria of DSM-IV-TR ; Referred to the psychiatric clinic Fatemi Hospital.

Exclusion criteria:Individual or patient reluctance to participate in the study; History of other psychiatric disorders, patients who are currently treated with other drugs; History of known medical condition under treatment .

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath